News

The collaboration between the Serum Institute of India Pvt. Ltd and the University of Oxford will provide lifesaving protection against Men-B through the production of a chimeric protein-based vaccine.

A pioneer in the field of leukocyte membrane proteins, Alan Williams was elected Head of Department in 1991. The unveiling of the new photographic portrait was hosted by the current Head of Department Professor Matthew Freeman earlier this year, in the company of friends and family.

In a study published in Nature Structural & Molecular Biology, the Proudfoot lab demonstrates how the use of dCas9 might affect transcriptional elongation and RNA processing, and how it can be harnessed to manipulate Pol II progression along the gene.

It has been announced that Professor Chris Tang of the Dunn School has been elected to the Fellowship of the American Society of Microbiology, one of the largest and oldest professional societies.

Dr Hinch’s team studies mechanisms of meiosis and germline mutagenesis, with a focus on their impacts on human health.

Recognised as a world leader in mammalian developmental genetics, Professor Liz Robertson has been awarded the title of Commander of the Order of the British Empire (CBE) in the 2024 New Year’s Honours list, announced over the weekend by Buckingham Palace.

In a career journey that transcends boundaries, Omphemetse Mooki's story stands as a testament to the limitless possibilities that determination and a pursuit of excellence can achieve.

As part of fostering a culture of respect and inclusivity, the Dunn School of Pathology hosted a Responsible Bystander Workshop on 15 November.

Dunn School Group Leader Fumiko Esashi has been awarded a BBSRC Pioneer Award to support her research on centromere evolution.

Contributions of Dr Kuang-Yu Chen to our understanding of host adaptation of SARS-CoV-2 earned her an esteemed Wellcome Trust grant.

Recognising her research on the cell biology of viral infection, as well as her teaching contributions, Sumana Sanyal has been awarded the title Professor of Molecular Pathology by the University of Oxford.

The honour recognises our previous Head of Department’s pioneering work in fundamental and therapeutic immunology research, which spearheaded the development of engineered antibodies for treatment of cancer, multiple sclerosis and other immune disorders.